Zou Qiang, Wang Hong-ying, Zhou Jian, Lao Zheng-yin, Xue Jun, Li Ming-xin, Li Hai-ming, Jin Yi-ting, Gu Yong, Zhang Yan-ling
Department of Surgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
Chin Med J (Engl). 2007 Oct 20;120(20):1777-82.
Drug treatment for secondary hyperparathyroidism caused by chronic renal failure may be available at the early stage of the disease, but it is not as effective for serious patients. The aim of the study was to evaluate the effect of total parathyroidectomy combined with forearm autotransplantation in the uremic patients with secondary hyperparathyroidism.
From September 1999 through September 2006, parathroidectomy and autotransplantation was performed in 20 patients. The coherence between the results of preoperative parathyroid ultrasonography and surgical exploration were compared. The serum calcium concentration and intact parathyroid hormone (iPTH) were monitored preoperatively, intraoperatively, and postoperatively.
A total of 71 hyperplastic parathyroid glands were resected in the 20 patients. The accordance rate of parathyroid localization between B-ultrasonography and intraoperative exploration was 94.4%. The average iPTH value was (110.90 +/- 67.42) ng/L, (433.80 +/- 243.72) ng/L, (48.80 +/- 42.69) ng/L, (229.04 +/- 172.68) ng/L and (232.39 +/- 224.05) ng/L at day 1, 2, 3, 7, 30 after operation respectively. The clinical symptoms were ameliorated and the levels of serum calcium concentration were controlled within the normal range after operation. Recurrent secondary hyperparathyroidism had happened in 1 case, 4 years postoperatively because of the development of autograft hyperplasia, and in another case 2 years postoperatively due to remnant of neck parathyroid glands. The clinical symptoms were all alleviated after re-operation. No surgical complication had occurred in any of the patients.
The total parathyroidectomy with forearm autotransplantation is feasible, safe, and effective for patients with secondary hyperparathyroidism in the short term. The long-term effects should be further investigated.
慢性肾衰竭所致继发性甲状旁腺功能亢进的药物治疗在疾病早期可能有效,但对重症患者效果不佳。本研究旨在评估甲状旁腺全切术联合前臂自体移植术治疗尿毒症继发性甲状旁腺功能亢进患者的疗效。
1999年9月至2006年9月,对20例患者施行甲状旁腺切除术及自体移植术。比较术前甲状旁腺超声检查结果与手术探查结果的一致性。术前、术中及术后监测血清钙浓度和完整甲状旁腺激素(iPTH)。
20例患者共切除71个增生的甲状旁腺。B超检查与术中探查甲状旁腺定位的符合率为94.4%。术后第1天、2天、3天、7天、30天的iPTH平均水平分别为(110.90±67.42)ng/L、(433.80±243.72)ng/L、(48.80±42.69)ng/L、(229.04±172.68)ng/L和(232.39±224.05)ng/L。术后临床症状改善,血清钙浓度控制在正常范围内。1例患者术后4年因自体移植增生复发继发性甲状旁腺功能亢进,另1例患者术后2年因颈部甲状旁腺残留复发。再次手术后临床症状均缓解。所有患者均未发生手术并发症。
甲状旁腺全切术联合前臂自体移植术治疗继发性甲状旁腺功能亢进患者短期内可行、安全且有效。其长期效果有待进一步研究。